NCT03667846View on ClinicalTrials.gov

Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD

PHASE2RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 10, 2019

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
Post Traumatic Stress DisorderAlcohol Use Disorder
Interventions
DRUG

Topiramate

Generic topiramate, FDA-approve for clinical use, will be purchased in 25mg, 50mg, and 100mg strengths, and encapsulated.

OTHER

Placebo

Placebo tablets will be encapsulated in identical capsules.

Trial Locations (1)

10016

RECRUITING

New York University School of Medicine, New York

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

NYU Langone Health

OTHER